These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7609062)

  • 1. Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.
    Araujo JC; Doniger J; Kashanchi F; Hermonat PL; Thompson J; Rosenthal LJ
    J Virol; 1995 Aug; 69(8):4933-40. PubMed ID: 7609062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.
    Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A
    J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
    Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
    Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames.
    Flebbe-Rehwaldt LM; Wood C; Chandran B
    J Virol; 2000 Dec; 74(23):11040-54. PubMed ID: 11069999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer.
    Ensoli B; Lusso P; Schachter F; Josephs SF; Rappaport J; Negro F; Gallo RC; Wong-Staal F
    EMBO J; 1989 Oct; 8(10):3019-27. PubMed ID: 2573513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
    Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
    J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. trans-activation of the HIV promoter by a cDNA and its genomic clones of human herpesvirus-6.
    Zhou Y; Chang CK; Qian G; Chandran B; Wood C
    Virology; 1994 Mar; 199(2):311-22. PubMed ID: 8122364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression.
    Thomson BJ; Weindler FW; Gray D; Schwaab V; Heilbronn R
    Virology; 1994 Oct; 204(1):304-11. PubMed ID: 8091661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat.
    Di Luca D; Secchiero P; Bovenzi P; Rotola A; Caputo A; Monini P; Cassai E
    AIDS; 1991 Sep; 5(9):1095-8. PubMed ID: 1657039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6.
    Martin ME; Nicholas J; Thomson BJ; Newman C; Honess RW
    J Virol; 1991 Oct; 65(10):5381-90. PubMed ID: 1654446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1.
    Thompson J; Choudhury S; Kashanchi F; Doniger J; Berneman Z; Frenkel N; Rosenthal LJ
    Oncogene; 1994 Apr; 9(4):1167-75. PubMed ID: 8134119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus and human herpesvirus-6 trans-activate the HIV-1 long terminal repeat via multiple response regions in human fetal astrocytes.
    McCarthy M; Auger D; He J; Wood C
    J Neurovirol; 1998 Oct; 4(5):495-511. PubMed ID: 9839647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of gene expression by human herpesvirus 6 is reporter gene-dependent.
    Campbell ME; McCorkindale S; Everett RD; Onions DE
    J Gen Virol; 1991 May; 72 ( Pt 5)():1123-30. PubMed ID: 1851812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions.
    Oelze I; Rittner K; Sczakiel G
    J Virol; 1994 Feb; 68(2):1229-33. PubMed ID: 8289357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.
    Duan L; Ozaki I; Oakes JW; Taylor JP; Khalili K; Pomerantz RJ
    J Virol; 1994 Jul; 68(7):4302-13. PubMed ID: 8207805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.